BLMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Based on the data provided, Bloomin' Brands Inc (BLMN) does not present a compelling buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock's recent financial performance is weak, with declining net income, EPS, and gross margin. Additionally, the stock has seen a significant regular market drop (-6.64%) and lacks strong positive trading signals or catalysts to suggest immediate upside potential. While there is some optimism from analysts regarding a turnaround and the stock's inclusion in high dividend-yielding stocks, the overall sentiment and technical indicators suggest a cautious approach.
The MACD is slightly positive (0.0141) but contracting, indicating weakening momentum. The RSI (39.165) is in the neutral zone, suggesting no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend direction. The stock is currently trading near its support level (S1: 6.029), with resistance levels at R1: 7.175 and R2: 7.529. Overall, the technical indicators do not suggest a strong buy signal.
Analysts have highlighted the company's potential for a turnaround driven by sales initiatives and operational improvements.
Inclusion in high dividend-yielding stocks, which are attracting investor interest during market turbulence.
Significant regular market price drop (-6.64%) and weak financial performance in the latest quarter.
BofA recently lowered the price target to $5 and maintained an Underperform rating.
No recent trading activity from insiders, hedge funds, or Congress to suggest confidence in the stock.
In Q3 2025, revenue increased by 2.07% YoY to $928.81M, but net income dropped significantly (-763.47% YoY) to -$45.86M. EPS also declined sharply (-775.00% YoY) to -$0.54, and gross margin decreased slightly (-1.31% YoY) to 65.54%. Overall, the company's financial performance shows significant challenges.
Freedom Capital initiated coverage with a Buy rating and a $10 price target, citing potential for a turnaround. However, BofA recently lowered its price target to $5 and maintained an Underperform rating. The analyst sentiment is mixed, with some optimism about future growth but concerns about current performance.
